Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 40

1.

How rational drug use reduces trypanosome infections in cattle in chemo-resistance hot-spot villages of northern Togo.

Tchamdja E, Clausen PH, Kulo AE, Batawui K, Bauer B, Den Abbeele JV, Delespaux V, Hoppenheit A.

Acta Trop. 2019 Feb;190:159-165. doi: 10.1016/j.actatropica.2018.11.023. Epub 2018 Nov 19.

PMID:
30465741
2.

Metformin use associated with protective effects for ocular complications in patients with type 2 diabetes - observational study.

Maleškić S, Kusturica J, Gušić E, Rakanović-Todić M, Šečić D, Burnazović-Ristić L, Kulo A.

Acta Med Acad. 2017 Nov;46(2):116-123. doi: 10.5644/ama2006-124.196.

3.

Amikacin Pharmacokinetics To Optimize Dosing in Neonates with Perinatal Asphyxia Treated with Hypothermia.

Cristea S, Smits A, Kulo A, Knibbe CAJ, van Weissenbruch M, Krekels EHJ, Allegaert K.

Antimicrob Agents Chemother. 2017 Nov 22;61(12). pii: e01282-17. doi: 10.1128/AAC.01282-17. Print 2017 Dec.

4.

Body weight, gender and pregnancy affect enantiomer-specific ketorolac pharmacokinetics.

Välitalo PA, Kemppainen H, Kulo A, Smits A, van Calsteren K, Olkkola KT, de Hoon J, Knibbe CAJ, Allegaert K.

Br J Clin Pharmacol. 2017 Sep;83(9):1966-1975. doi: 10.1111/bcp.13311. Epub 2017 May 14.

5.

Cattle breeding, trypanosomosis prevalence and drug resistance in Northern Togo.

Tchamdja E, Kulo AE, Vitouley HS, Batawui K, Bankolé AA, Adomefa K, Cecchi G, Hoppenheit A, Clausen PH, De Deken R, Van Den Abbeele J, Marcotty T, Delespaux V.

Vet Parasitol. 2017 Mar 15;236:86-92. doi: 10.1016/j.vetpar.2017.02.008. Epub 2017 Feb 14.

PMID:
28288771
6.

Enantiomer-specific ketorolac pharmacokinetics in young women, including pregnancy and postpartum period.

Kulo A, Smits A, Maleškić S, Van de Velde M, Van Calsteren K, De Hoon J, Verbesselt R, Deprest J, Allegaert K.

Bosn J Basic Med Sci. 2017 Feb 21;17(1):54-60. doi: 10.17305/bjbms.2016.1515.

7.

The amikacin research program: a stepwise approach to validate dosing regimens in neonates.

Smits A, Kulo A, van den Anker J, Allegaert K.

Expert Opin Drug Metab Toxicol. 2017 Feb;13(2):157-166. doi: 10.1080/17425255.2017.1234606. Epub 2016 Sep 21. Review.

PMID:
27623706
8.

Drug quality analysis through high performance liquid chromatography of isometamidium chloride hydrochloride and diminazene diaceturate purchased from official and unofficial sources in Northern Togo.

Tchamdja E, Kulo AE, Akoda K, Teko-Agbo A, Assoumy AM, Niang EM, Batawui K, Adomefa K, Bankolé AA, Kombiagou K, Hoppenheit A, Clausen PH, Mattioli RC, Peter R, Napier GB, De Deken R, Marcotty T, Van Den Abbeele J, Delespaux V.

Prev Vet Med. 2016 Apr 1;126:151-8. doi: 10.1016/j.prevetmed.2016.02.001. Epub 2016 Feb 4.

PMID:
26907208
9.

Paracetamol pharmacokinetics and metabolism in young women.

Allegaert K, Peeters MY, Beleyn B, Smits A, Kulo A, van Calsteren K, Deprest J, de Hoon J, Knibbe CA.

BMC Anesthesiol. 2015 Nov 13;15:163. doi: 10.1186/s12871-015-0144-3.

10.

Estradiol and weight are covariates of paracetamol clearance in young women.

Beleyn B, Vermeersch S, Kulo A, Smits A, Verbesselt R, de Hoon JN, Van Calsteren K, Allegaert K.

Gynecol Obstet Invest. 2014;77(4):211-6. doi: 10.1159/000358394. Epub 2014 Mar 25.

PMID:
24686129
11.

Weight, pregnancy and oral contraceptives affect intravenous paracetamol clearance in young women.

Kulo A, Van Calsteren K, van de Velde M, Mulabegovic N, Verbesselt R, de Hoon JN, Verhaeghe J, Allegaert K.

Eur Rev Med Pharmacol Sci. 2014;18(5):599-604.

12.

Deletion in the gene BruAb2_0168 of Brucella abortus strains: diagnostic challenges.

Dean AS, Schelling E, Bonfoh B, Kulo AE, Boukaya GA, Pilo P.

Clin Microbiol Infect. 2014 Sep;20(9):O550-3. doi: 10.1111/1469-0691.12554. Epub 2014 Feb 10.

13.

Potential risk of regional disease spread in West Africa through cross-border cattle trade.

Dean AS, Fournié G, Kulo AE, Boukaya GA, Schelling E, Bonfoh B.

PLoS One. 2013 Oct 9;8(10):e75570. doi: 10.1371/journal.pone.0075570. eCollection 2013.

14.

Epidemiology of brucellosis and q Fever in linked human and animal populations in northern togo.

Dean AS, Bonfoh B, Kulo AE, Boukaya GA, Amidou M, Hattendorf J, Pilo P, Schelling E.

PLoS One. 2013 Aug 12;8(8):e71501. doi: 10.1371/journal.pone.0071501. eCollection 2013.

15.

Paracetamol and ketorolac pharmacokinetics and metabolism at delivery and during postpartum.

Allegaert K, van Calsteren K, Hendrickx S, Kelchtermans J, Smits A, Kulo A, van de Velde M.

Acta Anaesthesiol Belg. 2012;63(3):121-5.

PMID:
23397664
16.

Biochemical tolerance during low dose propylene glycol exposure in neonates: A formulation-controlled evaluation.

Kulo A, Smits A, Naulaers G, de Hoon J, Allegaert K.

Daru. 2012;20(1):5. doi: 10.1186/1560-8115-20-5. Epub 2012 Jul 19.

17.

The impact of pregnancy on urinary ketorolac metabolites after single intravenous bolus.

Kulo A, Hendrickx S, de Hoon J, Mulabegovic N, van Calsteren K, Verbesselt R, Allegaert K.

Eur J Drug Metab Pharmacokinet. 2013 Mar;38(1):1-4. doi: 10.1007/s13318-012-0108-7. Epub 2012 Nov 21.

PMID:
23179562
18.

Urinary metabolites after intravenous propofol bolus in neonates.

Smits A, Verbesselt R, Kulo A, Naulaers G, de Hoon J, Allegaert K.

Eur J Drug Metab Pharmacokinet. 2013 Jun;38(2):97-103. doi: 10.1007/s13318-012-0109-6. Epub 2012 Nov 17.

PMID:
23161395
19.

The pharmacokinetics of a high intravenous dose of paracetamol after caesarean delivery: the effect of gestational age.

Allegaert K, Kulo A, Verbesselt R, Hopchet L, Deprest J, de Hoon J, Devlieger R, van de Velde M.

Eur J Anaesthesiol. 2012 Oct;29(10):484-8. doi: 10.1097/EJA.0b013e32835543a0.

PMID:
22935956
20.

Pharmacokinetics of intravenous ketorolac following caesarean delivery.

Kulo A, van de Velde M, van Calsteren K, Smits A, de Hoon J, Verbesselt R, Deprest J, Allegaert K.

Int J Obstet Anesth. 2012 Oct;21(4):334-8. doi: 10.1016/j.ijoa.2012.06.001. Epub 2012 Aug 15.

PMID:
22901775
21.

Effective analgesia after cesarean delivery needs pharmacokinetic input.

Kulo A, de Hoon J, Mulabegovic N, Allegaert K.

J Anaesthesiol Clin Pharmacol. 2012 Jul;28(3):409-10. doi: 10.4103/0970-9185.98375. No abstract available.

22.

Pharmacokinetics of paracetamol and its metabolites in women at delivery and post-partum.

Kulo A, Peeters MY, Allegaert K, Smits A, de Hoon J, Verbesselt R, Lewi L, van de Velde M, Knibbe CA.

Br J Clin Pharmacol. 2013 Mar;75(3):850-60. doi: 10.1111/j.1365-2125.2012.04402.x.

23.

Cefazolin plasma protein binding and its covariates in neonates.

Smits A, Kulo A, Verbesselt R, Naulaers G, de Hoon J, Vermeersch P, Allegaert K.

Eur J Clin Microbiol Infect Dis. 2012 Dec;31(12):3359-65. doi: 10.1007/s10096-012-1703-x. Epub 2012 Jul 26.

PMID:
22833246
24.

The impact of Caesarean delivery on paracetamol and ketorolac pharmacokinetics: a paired analysis.

Kulo A, van Calsteren K, Verbesselt R, Smits A, Devlieger R, de Hoon J, Allegaert K.

J Biomed Biotechnol. 2012;2012:437639. doi: 10.1155/2012/437639. Epub 2012 May 20.

25.

The propylene glycol research project to illustrate the feasibility and difficulties to study toxicokinetics in neonates.

Kulo A, de Hoon JN, Allegaert K.

Int J Pharm. 2012 Oct 5;435(2):112-4. doi: 10.1016/j.ijpharm.2012.05.014. Epub 2012 May 26.

PMID:
22641171
26.

Pharmacokinetics of drugs in neonates: pattern recognition beyond compound specific observations.

Smits A, Kulo A, de Hoon JN, Allegaert K.

Curr Pharm Des. 2012;18(21):3119-46. Review.

PMID:
22564304
27.

Developmental pharmacokinetics of propylene glycol in preterm and term neonates.

De Cock RF, Knibbe CA, Kulo A, de Hoon J, Verbesselt R, Danhof M, Allegaert K.

Br J Clin Pharmacol. 2013 Jan;75(1):162-71. doi: 10.1111/j.1365-2125.2012.04312.x.

28.

Pharmacokinetics of Drugs in Neonates: Pattern Recognition Beyond Compound Specific Observations.

Smits A, Kulo A, de Hoon JN, Allegaert K.

Curr Pharm Des. 2012 Feb 27. [Epub ahead of print]

PMID:
22385063
29.

Pharmacokinetics of a loading dose of intravenous paracetamol post caesarean delivery.

Kulo A, van de Velde M, de Hoon J, Verbesselt R, Devlieger R, Deprest J, Allegaert K.

Int J Obstet Anesth. 2012 Apr;21(2):125-8. doi: 10.1016/j.ijoa.2011.12.007. Epub 2012 Feb 15.

PMID:
22341787
30.

Hematologic and laboratory parameters in patientis with peptic ulcer bleeding treated by two modalities of endoscopic haemostasis and proton pump inhibitors.

Mehmedović-Redzepović A, Mesihović R, Prnjavorac B, Kulo A, Merlina K.

Med Glas (Zenica). 2011 Feb;8(1):151-7.

PMID:
21263414
31.

Better stability of acenocoumarol compared to warfarin treatment in one-year observational, clinical study in patients with nonvalvular atrial fibrillation.

Kulo A, Kusturica J, Kapić E, Becić F, Rakanović-Todić M, Burnazović-Ristić L, Mehmedović A, Lepar O, Mulabegović N.

Med Glas (Zenica). 2011 Feb;8(1):9-14.

PMID:
21263388
32.

Does intravenous paracetamol administration affect body temperature in neonates?

Hopchet L, Kulo A, Rayyan M, Verbesselt R, Vanhole C, de Hoon JN, Allegaert K.

Arch Dis Child. 2011 Mar;96(3):301-4. doi: 10.1136/adc.2010.203778. Epub 2011 Jan 12.

PMID:
21233080
33.

Prospective assessment of short-term propylene glycol tolerance in neonates.

Allegaert K, Vanhaesebrouck S, Kulo A, Cosaert K, Verbesselt R, Debeer A, de Hoon J.

Arch Dis Child. 2010 Dec;95(12):1054-8. doi: 10.1136/adc.2010.190330. Epub 2010 Oct 19.

PMID:
20959360
34.

Outpatient management of oral anticoagulation therapy in patients with nonvalvular atrial fibrillation.

Kulo A, Mulabegović N, Kusturica J, Hadzić H, Burnazović-Ristić L, Rakanović-Todić M, Mehmedović A, Lepara O.

Bosn J Basic Med Sci. 2009 Nov;9(4):313-9.

35.

Elevated serum homocysteine level is not associated with serum C-reactive protein in patients with probable Alzheimer's disease.

Lepara O, Alajbegovic A, Zaciragic A, Nakas-Icindic E, Valjevac A, Lepara D, Hadzovic-Dzuvo A, Fajkic A, Kulo A, Sofic E.

J Neural Transm (Vienna). 2009 Dec;116(12):1651-6. doi: 10.1007/s00702-009-0325-7. Epub 2009 Oct 7.

PMID:
19809863
36.

Resistance of goat nematodes to multiple anthelmintics on a farm in France.

Paraud C, Kulo A, Pors I, Chartier C.

Vet Rec. 2009 May 2;164(18):563-4. No abstract available.

PMID:
19411690
37.

[Esophageal closure and the efficacy of febantel against Muellerius capillaris in goats].

Chartier C, Kulo A, Delatour P, Cabaret J.

Can Vet J. 1995 Nov;36(11):714-6. French. No abstract available.

38.

Individual fluctuations in efficacy of febantel against Muellerius capillaris in goats.

Chartier C, Kulo A, Cabaret J, Pors I, Benoit C.

Vet Res. 1995;26(2):116-23.

PMID:
7735302

Supplemental Content

Support Center